The Discounted Cash Flow (DCF) valuation of Travere Therapeutics Inc (TVTX) is (144.95) USD. With the latest stock price at 27.32 USD, the upside of Travere Therapeutics Inc based on DCF is -630.6%.
Based on the latest price of 27.32 USD and our DCF valuation, Travere Therapeutics Inc (TVTX) is a sell. selling TVTX stocks now will result in a potential gain of 630.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.4% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (436.19) - (90.39) | (144.95) |
| Upside | -1696.6% - -430.9% | -630.6% |